Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07310342

Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura

Patients with chronic immune thrombocytopenic purpura (ITP) live with an anxiety-inducing risk of haemorrhage that is unpredictable over several months or years.

They also rate fatigue as one of the most frequent (48%) and most severe (73%) disabling symptoms, which contributes to a reduced quality of life [Cooper, 2021].

In this autoimmune disease targeting platelets, fatigue could be mediated by platelet and immunological abnormalities, and/or promoted by psychobehavioural determinants that are poorly understood in this chronic disease.

Since 1980, the World Health Organisation has stated that functional capacity assessments best reflect the impact of chronic diseases on quality of life, with fatigue playing an important role. The association between fatigue and aerobic physical capacity, determined by maximum oxygen consumption (VO2max), has been demonstrated in several pathologies. It is often associated with the vicious circle of deconditioning, where the impact of the disease on cardiac, muscular and respiratory functions is intertwined with inactive or sedentary behaviours.

At the end of this vicious circle, adults have been shown to have an increased cardiovascular risk and a high prevalence of anxiety and depression syndromes.

VO2max measured by cardiopulmonary exercise testing (CPET) is increasingly used in monitoring, as recommended by the French Society of Cardiology [Marcadet, 2018;Marcadet, 2019]. Our team (Amedro et al.) has set up a research programme on aerobic physical capacity and deconditioning to exercise in chronic childhood diseases and has just published the reference values for exercise tests in healthy paediatric populations, enabling the interpretation of VO2max results in sick children [Gavotto,2023].

However, it has been demonstrated that the VO₂ plateau is not predominantly reached in healthy adults and is rarely reached (<25%) in healthy children. [Armstrong, 1996 ; Åstrand, 1952 ; Rowland, 1992].

Thus, the highest oxygen consumption measurement (VO2pic) is often used instead of VO2max to define aerobic capacity. We will therefore use the concepts of VO2max and VO2pic in this study.

The first population studied by our team was children with congenital heart disease, who showed a significant reduction in their VO2max [Amedro, 2018]. Based on these results, a functional rehabilitation programme (QUALIREHAB) was set up and evaluated in a randomised controlled clinical trial [Amedro, 2019] . The data demonstrate its positive impact not only on VO2max, but also on quality of life. Aerobic physical capacity was assessed in chronic paediatric diseases without direct cardiac involvement.

We have also shown that VO2max declines more rapidly over time in children, adolescents and young adults who have survived childhood cancer [Gavotto, 2023] or in children with asthma [Moreau, 2023].

To date, no prospective controlled studies have reported on the level of aerobic physical capacity in children, adolescents and young adults with cITP.

We therefore hypothesise that fatigue in patients monitored for cITP could be correlated with a decrease in their aerobic physical capacity, causing these patients to enter a 'vicious cycle of deconditioning'. If this hypothesis is verified, an exercise rehabilitation programme could have a positive impact on quality of life, physical health and mental health

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

8 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Armand de Villeneuve Hospital - Montpellier University Hospital, Montpellier, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children, adolescents and young adults aged 8 to 25 followed for ITPc
  • Patient referred as part of routine care by a CEREVANCE network expert physician to an exercise physiology laboratory for fitness assessment

Exclusion criteria

  • Presence of at least one contraindication to performing an exercise test
  • Acute anemia < 9g or poorly tolerated chronic anemia, fever, uncontrolled asthma, respiratory failure, acute myocarditis or pericarditis, uncontrolled arrhythmias causing symptoms or hemodynamic disturbance, uncontrolled heart failure, acute pulmonary embolism or pulmonary infarction,
  • Patients with mental impairment leading to an inability to cooperate, as assessed by the physician during the history,
  • Clinical examination abnormalities (heart murmur, rhythm disorders).
  • Opposition to participation expressed by the parent(s) or legal guardian(s) for minors (<18 years) or by the patient.
  • Absence of social security

Treatment and study plan

IPT-CPET

Other

Patients with ITP will undergo standard care, medical examination, cardiopulmonary exercise test (CPET), muscular strength and physical activity tests, and validated questionnaires of health-related and disease-related quality of life, mental health, and physical activity

Primary outcomes

  1. VO2max measured by exercise testing

    Time frame: Day 1

    Values will be standardised using paediatric reference values.

Secondary outcomes

  1. First ventilatory threshold (SV1)

    Time frame: Day 1

    as a percentage of theoretical VO2max

  2. Ventilatory efficiency

    Time frame: Day 1

    VE/VCO2 slope

  3. Maximal power

    Time frame: Day 1

  4. Oxygen pulse

    Time frame: Day 1

  5. Maximum heart rate

    Time frame: Day 1

  6. Respiratory exchange ratio

    Time frame: Day 1

  7. Respiratory reserve

    Time frame: Day 1

  8. Health-related quality of life

    Time frame: Day 1

    PedsQL®

  9. Disease-specific quality of life

    Time frame: Day 1

    Kids ITP Tools

  10. Muscular force evaluation

    Time frame: Day 1

    Handgrip®

  11. Muscular force evaluation

    Time frame: Day 1

    standing long jump

  12. Physical activity evaluation

    Time frame: Between Day 1 and Day 7

    level of physical activity evaluated using an accelerometer

  13. Physical activity evaluation

    Time frame: Day 1

    • Children and Adolescents Physical Activity and Sedentary Questionnaire
    • International Physical Activity Questionnaire
  14. Mental health evaluation

    Time frame: Day 1

    • Strenghts and difficulties questionnaire
    • Adolescent Depression Rating Scale
    • Patient Health Questionnaire (PHQ-9)
  15. Fatigue evaluation

    Time frame: Day 1

    Fat-PTI questionnaire

Study contacts

Contact information is provided by the study sponsor or research team.

Marion AUDIE, MD

CONTACT

[email protected]

+330557656465 ext. +33

Nathalie ALADJIDI, MD

CONTACT

[email protected]

+33 05 57 82 02 61 ext. +33

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Registry information

Official study title

Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura: a Prospective, Multicentre, Controlled National Study

Acronym: ITP-CPET

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 30, 2025
Registry last updated
Dec 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.